|
End-of-day quote
Korea S.E.
02/11/2026
|
5-day change | 1st Jan Change | ||
| 10,670.00 KRW | +1.52% |
|
+1.43% | -16.96% |
| 02-09 | JW Lifescience Corporation announces Annual dividend, payable on April 24, 2026 | CI |
| 11-05 | JW Life Science Q3 operating profit 6.6 billion won, down 30% from year earlier | RE |
| Market Cap | 165B 123M 110M 101M 91.56M 172M 11.63B 175M 1.2B 485M 6.14B 461M 451M 19.39B | P/E 2024 |
3.83x | P/E 2025 | 6.96x |
|---|---|---|---|---|---|
| Enterprise Value | 205B 153M 136M 125M 114M 213M 14.45B 218M 1.49B 602M 7.63B 573M 561M 24.09B | EV / Sales 2024 |
1.03x | EV / Sales 2025 | 0.93x |
| Free-Float |
54.08% | Yield 2024 |
4.6% | Yield 2025 | 4.28% |
| 1 day | +1.52% | ||
| 1 week | +1.43% | ||
| Current month | +1.52% | ||
| 1 month | -3.53% | ||
| 3 months | -4.22% | ||
| 6 months | -17.48% | ||
| Current year | -16.96% |
| 1 week | 10,430 |  | 10,680 |
| 1 month | 10,330 | | 11,080 |
| Current year | 10,330 | | 14,000 |
| 1 year | 10,330 | | 15,580 |
| 3 years | 10,000 | | 15,580 |
| 5 years | 10,000 | | 16,100 |
| 10 years | 10,000 | | 34,450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jung-Yeol Noh
CEO | Chief Executive Officer | 60 | 11/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Eun-Kyung Ham
BRD | Director/Board Member | 63 | 16/02/2017 |
Jung-Yeol Noh
BRD | Director/Board Member | 60 | - |
Byeong-Suk Lee
BRD | Director/Board Member | 70 | 28/03/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.52% | +1.43% | -20.67% | -15.18% | 122M | |
| -0.46% | +10.31% | +57.38% | +143.15% | 1,263B | |
| -0.97% | +1.60% | +45.26% | +80.09% | 658B | |
| -2.05% | +0.73% | +36.27% | +101.62% | 521B | |
| -1.54% | +0.18% | +53.06% | +66.79% | 391B | |
| -0.78% | +5.51% | +79.85% | +44.25% | 369B | |
| -1.69% | +3.17% | +32.18% | +55.35% | 307B | |
| -0.72% | +7.83% | +12.10% | +33.76% | 290B | |
| -0.12% | +4.68% | +57.09% | +74.59% | 252B | |
| -0.21% | +7.34% | +39.56% | +109.69% | 212B | |
| Average | -0.58% | +5.53% | +39.21% | +69.41% | 426.21B | |
| Weighted average by Cap. | -0.82% | +6.60% | +48.68% | +93.29% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 222B 165M 148M 136M 123M 231M 15.66B 236M 1.62B 653M 8.27B 621M 608M 26.11B | 258B 192M 171M 157M 143M 268M 18.15B 273M 1.88B 756M 9.58B 720M 704M 30.26B |
| Net income | 43.99B 32.71M 29.2M 26.8M 24.38M 45.7M 3.1B 46.61M 320M 129M 1.63B 123M 120M 5.16B | 28.61B 21.27M 18.99M 17.43M 15.85M 29.72M 2.01B 30.31M 208M 83.9M 1.06B 79.83M 78.13M 3.36B |
| Net Debt | 59.62B 44.33M 39.58M 36.32M 33.04M 61.94M 4.2B 63.17M 434M 175M 2.22B 166M 163M 7B | 40.08B 29.81M 26.61M 24.42M 22.21M 41.65M 2.82B 42.48M 292M 118M 1.49B 112M 109M 4.7B |
Employees
297
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/11/26 | ₩10,670.00 | +1.52% | 6,656 |
| 30/10/26 | ₩10,510.00 | -0.76% | 15,152 |
| 29/10/26 | ₩10,590.00 | +0.76% | 8,675 |
| 28/10/26 | ₩10,510.00 | +0.67% | 10,151 |
| 27/10/26 | ₩10,440.00 | +0.19% | 9,589 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- A234080 Stock
Select your edition
All financial news and data tailored to specific country editions
